Terminal transferase as a therapeutic target in leukemia cells.
Boston University Medical Center.
R
R
McCaffrey
R
R
Duff
K
K
Bulger
Z
Z
Spigelman
K
K
Flora
R
R
Schinazi
C K
CK
Chu
D000818:Animals; D002460:Cell Line; D004249:DNA Damage; D004253:DNA Nucleotidylexotransferase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D004261:DNA Replication / Q000187:drug effects; D016048:Dideoxyadenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D015224:Dideoxynucleosides / Q000378:metabolism / Q000494:pharmacology*; D007942:Leukemia, Experimental / Q000473:pathology*; D051379:Mice; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000187:drug effects* / Q000201:enzymology; D013329:Structure-Activity Relationship; D013379:Substrate Specificity
D015224:Dideoxynucleosides; D009363:Neoplasm Proteins; D016048:Dideoxyadenosine; D004253:DNA Nucleotidylexotransferase